What Ozempic Dose is Best for Weight Loss?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become one of the most sought-after GLP-1 medications for sustainable weight loss, with clinical trials showing an average 15% body weight reduction at therapeutic doses. However, the question of what dose works best is not answered by a single number—it depends on your individual tolerance, metabolism, and weight loss goals. PlexusDx compounds pharmaceutical-grade semaglutide and helps you find your optimal dose through evidence-based titration.

How Semaglutide Dosing Works for Weight Loss

Semaglutide for weight management is not taken at a fixed dose from day one. Instead, patients begin at a low starting dose and gradually increase over 16–20 weeks in a process called titration. This approach allows your body to adjust to the medication while minimizing gastrointestinal side effects like nausea, vomiting, and diarrhea. The standard titration schedule typically starts at 0.25 mg weekly, increasing by 0.25 mg every four weeks until reaching a therapeutic or target dose.

Most people reach meaningful weight loss results at doses between 1.0 mg and 2.4 mg weekly, depending on their individual response and tolerability. The FDA-approved dose for chronic weight management is 2.4 mg weekly, but many patients achieve excellent results at lower doses while experiencing fewer side effects. Your healthcare provider determines the best dose for you based on your weight loss trajectory, side effect profile, and overall health status.

Starting Dose vs. Maintenance Dose: What's the Difference

Your starting dose is intentionally low—typically 0.25 mg once weekly—to allow your body to acclimate to semaglutide's effects on appetite and blood sugar. This initial phase usually lasts four weeks before your dose increases. Starting low reduces the likelihood of severe nausea or other adverse reactions that could cause you to discontinue treatment. Many patients who start at a higher dose report dropping out of treatment due to intolerance.

Your maintenance dose is the dose at which you achieve your weight loss goals while maintaining acceptable side effects. For some people, this might be 1.0 mg weekly; for others, it could be 2.0 mg or higher. The maintenance phase begins once your dose is optimized, and you continue that dose weekly until you reach your target weight or decide to taper off. Importantly, your monthly cost at PlexusDx remains flat regardless of which maintenance dose you're using—your dose may go up, but your price won't.

Factors That Influence Your Ideal Semaglutide Dose

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Your eating patterns, activity level, and adherence to dietary changes also determine whether a lower or higher dose is necessary. Some patients reach their weight loss goals at 1.0 mg weekly with consistent diet changes, while others need 2.0 mg or more to suppress appetite effectively. Medications you take, kidney or liver function, and your history of pancreatitis or thyroid disease may require dose adjustments or alternative compounds. A licensed PlexusDx provider reviews all these factors to recommend your optimal starting and maintenance doses.

Semaglutide Dose Adjustments and When to Titrate Up or Down

If you're not experiencing adequate appetite suppression or weight loss after 4–8 weeks at your current dose, your provider may recommend a dose increase. Conversely, if you're experiencing severe nausea, vomiting, or other side effects that interfere with daily life, your dose may be reduced or kept steady while you adjust. Most people tolerate gradual increases better than jumps of more than 0.25 mg per week. Some patients stay at intermediate doses (like 0.75 mg or 1.5 mg) longer to maximize tolerability.

Weight loss typically plateaus after 12–16 weeks at a stable dose, which is normal and does not mean semaglutide has stopped working. A plateau often reflects reaching a new metabolic equilibrium and sustainable weight loss rate. If you wish to continue losing weight, a dose increase might help, but this should be discussed with your provider. PlexusDx allows you to adjust your treatment plan throughout your journey without penalty fees or price increases tied to your dose decisions.

Why Personalized Dosing Beats Generic Weight Loss Protocols

Generic weight loss advice often assumes everyone should follow the same dose progression, but this ignores genetic diversity in drug metabolism and appetite regulation. Two people of the same weight and age may need entirely different semaglutide doses to achieve comparable weight loss because their peptide pathways respond differently. The Precision Peptide Genetic Test from PlexusDx identifies whether you're a fast, average, or slow responder to GLP-1 signaling, helping your provider tailor your starting and titration schedule from the beginning.

Personalized dosing also reduces trial-and-error, wasted medication, and side effects that derail treatment. Compounded semaglutide from licensed 503A pharmacies offers flexible dosing options not available through commercial manufacturers, allowing your provider to adjust your dose in 0.05 or 0.1 mg increments if needed for precise titration. This customization, combined with genetic insights, increases the likelihood of finding your ideal dose faster and sustaining long-term weight loss success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly. This low initial dose minimizes nausea and allows your body to adapt over the first four weeks. After four weeks, your dose typically increases by 0.25 mg weekly until you reach your therapeutic dose, which varies by individual.

What is the maximum safe dose of semaglutide for weight loss?

The FDA-approved maximum dose for chronic weight management is 2.4 mg weekly. However, many patients achieve excellent results at 1.0–2.0 mg weekly with fewer side effects. Your provider determines your maximum safe dose based on your health status, tolerability, and weight loss response.

How long does it take to reach the maintenance dose?

Typical titration takes 16–20 weeks, with dose increases every four weeks. Some patients reach their target dose in 12–16 weeks if they tolerate increases well, while others may need a slower titration schedule. PlexusDx providers customize your timeline based on your side effect profile and weight loss progress.

Does my semaglutide cost increase if my dose goes up?

No. PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) and remains flat across commitment tiers—your dose may go up, but your price won't. There are no per-dose charges, dose-based tiers, or hidden fees.

Can I find my ideal dose without a genetic test?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What if I experience side effects at my current dose?

Notify your PlexusDx provider immediately. You may reduce your dose, stay at your current dose longer, or switch to oral semaglutide or another compound. Many side effects resolve within days to weeks as your body adjusts; your provider will help determine whether adjustment or time is best.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.